Ten symptoms of kidney disease

1.Changes in your urinary function
2.Difficulty or pain during voiding
3.Blood in the urine
4.Swelling
5.Extreme fatigue and generalised weakness
6.Dizziness & Inability to concentrate
7.Feeling cold all the time
8.Skin rashes and itching
9.Ammonia breath and metallic taste
10.Nausea and vomiting

Kidney Disease Main Risk for Diabetics

 The University of Washington study found that having kidney disease destined a much higher danger of early death. 

Diabetes mellitus type 2 (Type 2 diabetes) is a metabolic disorder caused by high blood glucose in the context of insulin resistance and relative insulin insufficiency.

According to the study, approximately 5% of people in the UK have been diagnosed with diabetes, and careful management of their condition through a combination of medication and routine changes can mean it has moderately little impact on their lives.

People with type-two diabetes have many additional risk factors for cardiovascular disease and mortality. Diabetic kidney disease could be prohibited using blood pressure medication. So we anticipated that kidney disease would predict a part, but not a majority, of higher death.Still, if the sickness has been present for some time prior to diagnosis, or is poorly managed afterwards, the risk of life-changing complications rises.

Diabetes can distress kidneys

According to a multi cultural study, the first time that several patients realise that diabetes can affect their kidneys is when they are referred to renal services. UK researchers who strut to 48 patients with diabetes attending expert renal services in Leicester, Luton and Ealing, discovered that awareness of the kidney risks posed by the disease was very low. "The people we spoke to knowledgeable feelings of surprise, fear and regret when they originate out their kidney had been affected" says Professor Gurch Randhawa, Director of the Institute for Health Research at the University of Bedfordshire and an expert in assortment in public health.

"Some patients saw their kidney referral as a ''wake-up call'' that they needed to control their diabetes more seriously, while others were worried about their lack of knowledge about the disease. What was clear was that several of the patients we spoke to were much additional aware of how diabetes could affect their eyes and feet than their kidneys. "We believe this study highlights a serious require for more information about the risks that diabetics face from kidney disease." Professor Randhawa teamed up with research fellow Emma Wilkinson to explore any variation in the experiences, knowledge and attitudes of white patients and South Asian patients.

"Previous UK studies have identified that South Asian patients have a better risk of developing diabetes-related end stage kidney failure" says Professor Randhawa. "Despite this, there is growing proof that they tend to be referred later for renal care and are more probable to be lost to follow-up." The 23 South Asian patients and 25 white patients who took part in the study were aged between 34 and 79 - with an normal age of just over 70. All had type 2 diabetes and had been conventional for clinical review at a specialist renal department. They had been analyze with diabetes for between six months and 40 years, with an average time since diagnosis of just below 15 years. Male patients accounted for 61 per cent of the South Asian grouping and 64 per cent of the white group.

Vegetarian diet well again for kidney disease

A U.S. doctor says phosphorus level stay lower in kidney disease patients who have a vegetarian diet. Dr. Sharon Moe of Indiana University School of Medicine in Indianapolis says patients with kidney disease cannot free their bodies of phosphorus and require to watch their intake of the mineral found in proteins because high levels can reason heart disease but phosphorus content is not scheduled on food labels. Moe and colleagues ask nine patients among chronic kidney disease to follow either a vegetarian or meat based diet for one week, follow by the opposed diet two-to four weeks later. Blood and urine tests were execute at the end of each week on both diets.

The study, listed to be published in the Clinical Journal of the American Society Nephrology, found study patients eating proteins from vegetables had inferior blood phosphorus levels and reduce phosphorus excretion vs. those eating a meat based diet. This was true despite together diets having equivalent levels of proteins and phosphorous. "These results, if confirmed in longer studies, provide rationale for recommending a prevalence of grain-based vegetarian sources of protein to patients with chronic kidney disease," the study researchers say in a report.

Blood experiment to predict kidney disease

A study has exposed that measuring three biomarkers in a single blood sample might improve physicians' ability to recognize patients at high risk of developing chronic kidney disease (CKD). "Our results recognize biomarkers that can develop CKD risk prediction," comments Caroline S. Fox, MPH of the National Heart, Lung, and Blood Institute's Framingham Heart Study, Framingham, Mass. The study included more than 2,300 participants in the Framingham Offspring Study, a long term follow-up study of heart disease risk factor and outcomes. All participants had usual kidney function when they provide blood samples in 1995-98. An average of 9.5 years later, nine percent of patients had expanded CKD.

Another eight percent had tall levels of protein in the urine at follow-up a key sign of deteriorating kidney function Stored blood samples from 1995-98 were experienced to see if any of six different biomarkers could predict which patients were most likely to expand CKD. A mixture of three biomarkers significantly improved the ability to recognize patients at high risk of CKD, including homocysteine, a marker of atherosclerosis risk, and aldosterone, a hormone that affect salt handling by the kidneys. The same two biomarkers also predict the risk of macroalbuminuria, as did B-type natriuretic peptide (BNP) an indicator of heart damage in patients with heart failure.

useful links : transport rankings  

FDA may control anemia drug use for kidney disease

The Food and Drug Administration is considering new limits on widely used anemia drugs that emerge to double the risk of stroke in patients with kidney disease. The FDA posted its safety appraisal of the three blood boosting medications from Amgen Inc. on Thursday, focusing on their use in patients with chronic kidney disease who are not yet sick sufficient to receive dialysis. The medicines Procrit, Aranesp and Epogen are multibillion dollar sellers because of their capability to boost oxygen-carrying red blood cells, reducing the require for painful blood transfusions. But sales have fallen stridently since 2007, when the FDA added the first of many safety warnings to the drugs, based on evidence they can cause tumor enlargement and hasten death in cancer patients. The drugs are no longer used in patients with several types of cancers.

Anemia, which causes weakness and smallness of breath, is a side result of chemotherapy and kidney failure. Now the FDA is review a study published last year that show kidney disease patients taking Aranesp were twice as likely to knowledge stroke compare with those taking a dummy treatment. The goal of the study was to show that the drug could avoid heart attack, stroke and other heart related problems, as had been assumed for years. But FDA reviewers, using the chemical name for Aranesp, said in their posting that the "proof raises considerable doubt about the safety and desirability of using darbepoetin in this manner."

Amgen has argued that its drugs should carry on to be used because they help avoid blood transfusions, which carry their own risks. But the FDA's scientists point out that 15 percent of patients who took the company's drug still wanted transfusions, compared with 25 percent of those taking a placebo treatment. "Treatment did not eliminate the risk of need transfusions," states the FDA review. On Monday the agency will ask a panel of outside expert to review the data and create recommendations on how to safely use the drugs. Panelists could recommend bolstered warning labels, extra studies or lower doses of the drugs. The FDA is not necessary to follow the group's advice, although it often does.

useful links : transport rankings

Moderate kidney disease associated to hearing loss

In the study, of adults aged 50 years and older, 54 percent of people with sensible kidney disease had some extent of hearing loss, while 30 percent of those with the disease suffered harsh hearing loss. That's higher than in the common population: According to the National Institute on Deafness and Other Communication Disorders, investigation loss affects 18 percent of U.S. adults aged 45 to 64. Earlier studies had shown a link between kidney disease and hearing loss in sure rare syndromes. However, the new study, published today in the American Journal of Kidney Diseases, expand on that by presentation that the link can exist for any older adult with kidney disease.

In the U.S., there are 31 million adults in the living with kidney disease, 7.5 million of whom have restrained forms. Given the new findings, researchers think that it is important for these patients to be aware of the link between their condition and hearing loss. "If you have kidney disease, you should discuss with your doctor about testing for hearing," said Dr. David Harris, a co-author of the study at Sydney Medical School in Australia. "It's a simple test, but will help you to take individual care if you do have a hearing impairment."

For most patients who lost hearing in the study, the loss was less than severe, only affecting decibel levels around that of a whisper or low discussion. Still, having a doctor help choose the suitable hearing aid can preserve hearing, say the authors. Because of the nature of the study, the results do not propose that kidney disease actually causes hearing loss, just that there is a link between the two. Dr. Robert Hopkin, who studies genetic disorders at Cincinnati Children's Hospital Medical Center, also pointed out that although this study shows effects in a huge population, for individuals there is still large variability. In other words, just because you have kidney disease, doesn't mean you're necessarily going to suffer hearing loss.

useful links : transport rankings

Fast Food and Cheap Eats related With Kidney Disease

McDonald’s, Burger King, Taco Bell.. They all entice us each day with their suitable locations, cheap prices, and tasty looks, but these foods are full of phosphates, which are shown to have unfavorable effects on people with kidney disease. A study done showed that people who do not have the means to buy healthy food eat fast food more repeatedly, in turn worsening kidney disease. Phosphorus is a mineral found in nature in foods like milk, cheese, beans and peanut butter. It is vital for the configuration of bones and teeth, as well as energy production and the formation of cell membranes. Since the kidneys leak excess phosphate, patients with Chronic Kidney Disease may develop increased blood levels of phosphate, or hyperphosphatemia.

Manufacturers add phosphates to foods to give them a longer shelf-life and make them more attractive. The studies analyze phosphate levels in the blood of patients participate in the Chronic Renal Insufficiency Cohort Study (CRIC). They inspected the risk factors for kidney disease progression and cardiovascular disease in patients with Chronic Kidney Disease. "A lot of studies have demonstrated that an elevated level of phosphate in the blood is associated with adverse outcomes in patients with chronic kidney disease and that blacks have higher phosphate levels than whites but we did not understand why levels are higher in blacks," Myles Wolf, MD, MMSc, senior author of the study was quoted as saying.

"Our earlier work in the general population recommended that poverty was linked to a higher phosphate level, so we decided to delve deeper into that connection in the setting of chronic kidney disease." There were 3,126 culturally and ethnically diverse participants, and those with the lowest incomes and those who were unemployed had more phosphate in their blood than those who were of high economic status. There was no variation in phosphate levels among blacks and whites who were unemployed or of lower income. The researchers completed that the known belief that blacks are more at risk for Chronic Kidney Disease is solely due to economic status, and not race.

useful links : transport rankings